SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

AQX Alice Queen Limited

Basic Materials · Other Industrial Metals & Mining · website
$0.01
52wk 0.00 – 0.02
Overall
39.5
Value
62.5
Growth
0.0
Health
100.0
Quality
0.0
Momentum
20.6
Dividend
—
Price
About Alice Queen Limited

Alice Queen Limited engages in the exploration of mineral properties in Australia and Fiji. The company explores for gold, copper, and critical mineral deposits. It owns flagship project the Horn Island Gold Project located on the eastern side of Horn Island in the Torres Strait, Queensland. The company was incorporated in 2002 and is based in South Yarra, Australia. Alice Queen Limited operates as a subsidiary of Gage Resource Development Pty Limited.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Copper
6.58 USD/lb
1m: 1.3% · 1y: 34.4%
Price analytics

Returns

1 day 0.0%
1 week 0.0%
1 month 0.0%
3 months 0.0%
6 months -30.0%
1 year 75.0%
3 years -41.7%

Risk

Volatility (1y ann.) 147.2%
Beta vs ASX 200 0.35
Sharpe (1y) 1.08
VaR 95% (1-day) -12.5%
Max drawdown (1y) -68.8%
Off 1-year high -56.3%

Technicals

RSI(14) 50
vs 50DMA 3.4%
vs 200DMA -15.4%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 62.5
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
62
Price / Sales
0
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 20.6
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
67
Position in 52-week range
31

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$16.24M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.48
EV / EBITDA
-2.73
Price / Book
3.50
ROE
-208.2%
Operating margin
-86,465.6%
Net margin
0.0%
Total cash
$3.60M
Total debt
$33,506
Current ratio
7.73
Debt / Equity
0.01
Free cash flow
$-1.39M
Avg volume
797,808
Latest annual results (FY ending 30 Jun 2025)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS-0.00
  • Free cash flow—
  • Net debt—
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6